149 related articles for article (PubMed ID: 34447604)
1. Digital Pathology-based Study of Cell- and Tissue-level Morphologic Features in Serous Borderline Ovarian Tumor and High-grade Serous Ovarian Cancer.
Jiang J; Tekin B; Guo R; Liu H; Huang Y; Wang C
J Pathol Inform; 2021; 12():24. PubMed ID: 34447604
[TBL] [Abstract][Full Text] [Related]
2. Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma.
Jiang J; Tekin B; Yuan L; Armasu S; Winham SJ; Goode EL; Liu H; Huang Y; Guo R; Wang C
Front Med (Lausanne); 2022; 9():994467. PubMed ID: 36160147
[TBL] [Abstract][Full Text] [Related]
3. Role of MRI in characterizing serous borderline ovarian tumor and its subtypes: Correlation of MRI features with clinicopathological characteristics.
Li K; Song F; Yu L; Shi H; Wang J; Cheng X
Eur J Radiol; 2022 Feb; 147():110112. PubMed ID: 34972058
[TBL] [Abstract][Full Text] [Related]
4. Serous surface papillary borderline ovarian tumors: correlation of sonographic features with clinic pathological findings.
Wang D; Su N; Wang R; Zhang L; Qi Z; Liu Z; Yang J; Leng J; Xiang Y;
Ultrasound Obstet Gynecol; 2024 May; 63(5):691-698. PubMed ID: 37592848
[TBL] [Abstract][Full Text] [Related]
5. Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers.
Bae G; Berezhnoy G; Koch A; Cannet C; Schäfer H; Kommoss S; Brucker S; Beziere N; Trautwein C
Front Mol Biosci; 2023; 10():1158330. PubMed ID: 37168255
[No Abstract] [Full Text] [Related]
6. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
7. EGF-induced EMT and invasiveness in serous borderline ovarian tumor cells: a possible step in the transition to low-grade serous carcinoma cells?
Cheng JC; Auersperg N; Leung PC
PLoS One; 2012; 7(3):e34071. PubMed ID: 22479527
[TBL] [Abstract][Full Text] [Related]
8. Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics.
Handley KF; Sims TT; Bateman NW; Glassman D; Foster KI; Lee S; Yao J; Yao H; Fellman BM; Liu J; Lu Z; Conrads KA; Hood BL; Barakat W; Zhao L; Zhang J; Westin SN; Celestino J; Rangel KM; Badal S; Pereira I; Ram PT; Maxwell GL; Eberlin LS; Futreal PA; Bast RC; Fleming ND; Conrads TP; Sood AK
JAMA Netw Open; 2022 Oct; 5(10):e2236626. PubMed ID: 36239936
[TBL] [Abstract][Full Text] [Related]
9. Characterization of immunoreactivity with whole-slide imaging and digital analysis in high-grade serous ovarian cancer.
Jäntti T; Luhtala S; Mäenpää J; Staff S
Tumour Biol; 2020 Nov; 42(11):1010428320971404. PubMed ID: 33169632
[TBL] [Abstract][Full Text] [Related]
10. Search for New Participants in the Pathogenesis of High-Grade Serous Ovarian Cancer with the Potential to Be Used as Diagnostic Molecules.
Timofeeva AV; Asaturova AV; Sannikova MV; Khabas GN; Chagovets VV; Fedorov IS; Frankevich VE; Sukhikh GT
Life (Basel); 2022 Dec; 12(12):. PubMed ID: 36556382
[TBL] [Abstract][Full Text] [Related]
11. Perfusion-based functional magnetic resonance imaging for differentiating serous borderline ovarian tumors from early serous ovarian cancers in a rat model.
Cai SQ; Li Y; Li YA; Wang L; Zhu J; Zhao SH; Qiang JW
Acta Radiol; 2021 Jan; 62(1):129-138. PubMed ID: 32276553
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer.
Li Y; Jaiswal SK; Kaur R; Alsaadi D; Liang X; Drews F; DeLoia JA; Krivak T; Petrykowska HM; Gotea V; Welch L; Elnitski L
BMC Cancer; 2021 Jul; 21(1):768. PubMed ID: 34215221
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated stroma significantly contributes to the mesenchymal subtype signature of serous ovarian cancer.
Zhang Q; Wang C; Cliby WA
Gynecol Oncol; 2019 Feb; 152(2):368-374. PubMed ID: 30448260
[TBL] [Abstract][Full Text] [Related]
14. Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes.
Jönsson JM; Johansson I; Dominguez-Valentin M; Kimbung S; Jönsson M; Bonde JH; Kannisto P; Måsbäck A; Malander S; Nilbert M; Hedenfalk I
PLoS One; 2014; 9(9):e107643. PubMed ID: 25226589
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
16. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Zhang C; Wang YE; Zhang P; Liu F; Sung CJ; Steinhoff MM; Quddus MR; Lawrence WD
Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693
[TBL] [Abstract][Full Text] [Related]
17. A data science approach for the classification of low-grade and high-grade ovarian serous carcinomas.
Lin S; Wang C; Zarei S; Bell DA; Kerr SE; Runger GC; Kocher JA
BMC Genomics; 2018 Nov; 19(1):841. PubMed ID: 30482155
[TBL] [Abstract][Full Text] [Related]
18. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
19. Platform-Independent Classification System to Predict Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.
Shilpi A; Kandpal M; Ji Y; Seagle BL; Shahabi S; Davuluri RV
JCO Clin Cancer Inform; 2019 Apr; 3():1-9. PubMed ID: 31002564
[TBL] [Abstract][Full Text] [Related]
20. Testing for
Sadlecki P; Grzanka D; Grabiec M
Dis Markers; 2018; 2018():1497879. PubMed ID: 29682098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
